Simultaneously with the introduction of neuroleptics, a “task force” was organized in Hungary for the study of hallucinogenic indoleamines. The leader of the group was St. Szara, and the purpose of the group was to elucidate the role of dimethyltriptamine and diethyltriptamine in the pathogenesis of schizophrenic disorders. It was in the course of clinical studies during this period that Z. Boszormenyi recognized the favorable effect of hallucinogenic indoleamines in the psychotherapy of neurotic patients. Several years later Leuner reported on similar results with LSD.
KeywordsPanic Disorder Organic Brain Syndrome Myoclonus Epilepsy Chronic Schizophrenic Neurotic Patient
Unable to display preview. Download preview PDF.